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ABSTRACT 
Gastroretentive systems can remain in the gastric region for several hours and significantly prolong the gastric residence of the drugs. Prolonged 
gastric retention improves bioavailability, reduces drug waste, improve solubility of drugs that are less soluble in a high pH environment. It has 
application also for local drug delivery to the stomach and proximal small intestine. The main objective of any drug therapy is to achieve  a desire 
concentration of the drug in blood or tissue  which is therapeutically effective and nontoxic  for extended period of time, and this goal can  be 
achieved by proper design of sustain release  dosage regimen. Microspheres have been widely accepted as a mean to achieve oral and parenteral 
controlled release. The microspheres require a polymeric substance as a coating material or carrier. A number of different substances 
biodegradable as well as non-biodegradable have been investigated for the preparation of microspheres. The aim of this study is to prepare 
floating microspheres containing Sulfasalazineto achieve a controlled drug release profile suitable for peroral administration. 
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INTRODUCTION 
Gastroretentive systems can remain in the gastric region for 
several hours and significantly prolong the gastric residence 
of the drugs. Prolonged gastric retention improves 
bioavailability, reduces drug waste, improve solubility of 
drugs that are less soluble in a high pH environment. It has 
application also for local drug delivery to the stomach and 
proximal small intestine.  
The main objective of any drug therapy is to achieve  a desire 
concentration of the drug in blood or tissue  which is 
therapeutically effective and nontoxic  for extended period of 
time, and this goal can  be achieved by proper design of 
sustain release  dosage regimen. Microspheres have been 
widely accepted as a mean to achieve oral and parenteral 
controlled release. The microspheres require a polymeric 
substance as a coating material or carrier. A number of 
different substances biodegradable as well as non-
biodegradable have been investigated for the preparation of 
microspheres. The aim of this study is to prepare floating 
microspheres containing Sulfasalazine to achieve a 
controlled drug release profile suitable for peroral 
administration.1-5 
MATERIALS AND METHODS 
Materials 
Sulfasalazine was generous gift sample from Valens 
molecules Pvt Ltd, Hyderabad. Polymers were obtained from 
Aurobindo Pharma Ltd, Hyderabad. All other chemicals and 
solvents are of analytical grade. 
Methods 
Preparation of Floating Microsphere of Sulfasalazine 
Floating microspheres containing aceclofenac were prepared 
using emulsion- solvent diffusion technique. The drug to 
polymer ratio used to prepare the different formulations was 
as shown in table 1. The drug polymer mixture dissolved in a 
mixture of ethanol (8 mL) and dichloromethane (8 mL) was 
dropped in to 0.2% sodium lauryl sulfate solution (400 ml). 
The solution was stirred with a propeller-type agitator at 
room temperature for 1 h at 500 rpm. The formed floating 
microspheres were filtered, washed with water and dried at 
room temperature in a desicator. The various batches of 
floating microsphere were prepared as follows.5,8-10 
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Table 1: Formulations of the Floating Microspheres Prepared 
Sr. No Formulation Code Sulfasalazine (mg) EC (mg) HPMC (mg) PVA (mg) 
1 F1 250 50 250 - 
2 F2 250 100 250 - 
3 F3 250 150 250 - 
4 F4 250 200 250 - 
5 F5 250 - 250 50 
6 F6 250 - 250 100 
7 F7 250 - 250 150 
8 F8 250 - 250 200 
 
 
Evaluation of Microspheres 
Particle size analysis:   
Particle size analysis plays an important role in determining 
the release characteristics and floating property. The sizes of 
floating microspheres were measured by using an optical 
microscope, and the mean particle size was calculated by 
measuring nearly 200 particles with the help of a calculated 
ocular micrometer.6-8 
 Floating behavior of Floating microsphere: 
100 mg of the floating microsphere were placed in 0.1 N HCI. 
The mixture was stirred with paddle at 100rpm. The layer of 
buoyant microspheres was pipetted and separated by 
filtration at 1, 2, 4 and 6 hours. The collected microspheres 
were dried in a desiccator over night.7-10The percentage of 
microspheres was calculated by the following equation: 
 
                      
                         
                                
      
 
Drug Entrapment 
The various formulations of the floating microspheres were 
subjected for drug content. 50 mg of floating microspheres 
from all batches were accurately weighed and crushed. The 
powdered of microspheres were dissolved with 10ml 
ethanol in 100ml volumetric flask and makeup the volume 
with 0.1 N HCl. This resulting solution is than filtered 
through whatmann filter paper No. 44. After filtration, from 
this solution 10 ml was taken out and diluted up to 100 ml 
with 0.1 N HCl and the absorbance was measured at 350.50 
nm against blank.6-9  The percentage drug entrapment was 
calculated as follows. 
 
                   
                             
                              
      
 
Percentage Yield 
The prepared microspheres with a size range of 609-874 µm 
were collected and weighed from different formulations. The 
measured weight was divided by the total amount of all non-
volatile components which were used for the preparation of 
the microspheres.6-11 
 
         
                       
                               
      
 
Shape and Surface Characterization of Floating 
Microspheres by Scanning Electron Microscopy:  
From the formulated batches of floating microspheres, 
formulations (F4) which showed an appropriate balance 
between the buoyancy and the percentage release were 
examined for surface morphology and shape using scanning 
electron microscope JEOL, JSM-670F Japan. Sample was fixed 
on carbon tape and fine gold sputtering was applied in a high 
vacuum evaporator. The acceleration voltage was set at 3.0 
KV during scanning. Microphotographs were taken on 
different magnification and higher magnification (500X) was 
used for surface morphology. 7-11 
In-vitro Release Studies 
The drug release rate from floating microspheres was 
carried out using the USP type II (Electro Lab.) dissolution 
paddle assembly. A weighed amount of floating 
microspheres equivalent to 100 mg drug were dispersed in 
900 ml of 0.1 N HCI (pH 1.2) maintained at 37± 0.5°C and 
stirred at 100 rpm. One ml sample was withdrawn at 
predetermined intervals and filtered and equal volume of 
dissolution medium was replaced in the vessel after each 
withdrawal to maintain sink condition. The collected 
samples were treated with methyl orange and analyzed 
spectrophotometrically at 350.50 nm to determine the 
concentration of drug present in the dissolution medium.5-10   
Drug Release Kinetic Data Analysis 
Several kinetic models have been proposed to describe the 
release characteristics of a drug from matrix. The following 
three equations are commonly used, because of their 
simplicity and applicability. Equation 1, the zero-order 
model equation (Plotted as cumulative percentage of drug 
released vs time); Equation 2, Higuchi’s square-root equation 
(Plotted as cumulative percentage of drug released vs square 
root of time); and Equation 3, the Korsmeyer-Peppa’s 
equation (Plotted as Log cumulative percentage of drug 
released vs Log time). 
RESULTS AND DISCUSSION 
Evaluation of sulfasalazine floating microspheres:  
Particle size analysis: 
Particle size was determined by Optical microscopy method. 
It plays important role in floating ability and release of drug 
from Microsphere. If size of Microspheres is less than 500 
m release rate of drug will be high and floating ability will 
reduce, white Microspheres ranging between 400m - 
600m, the floating ability will be more and release rate will 
be in sustained manner. The mean particle size of 
Sulfasalazine microsphere was in range 479.2 – 589.8 m as 
shown in Table 1.  
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Mean particle size of Different Batches of Sulfasalazine 
microsphere 
Table 2: Mean particle size of Different Batches of 
Sulfasalazine microsphere 
S. No Formulation code Mean particle size (m) 
1.  F1 479.2±15 
2.  F2 495.8±45 
3.  F3 490.2±32 
4.  F4 498.5±23 
5.  F5 512.2± 15 
6.  F6 545.6±22 
7.  F7 589.8±12 
8.  F8 521.2±21 
 
Figure 1: Mean particle size of Different Batches of 
Sulfasalazine microsphere 
Mean Particle size of Optimized Batch F1 
 
Figure 2: Mean Particle size of Optimized Batch 
 
Floating behavior of microsphere: 
Sulfasalazine Microsphere was dispersed in 0.1 HCl as 
simulate gastric fluid.  Floating ability of different 
formulation was found to be differed according to EC and 
HPMC ratio.  F1-F4 formulations showed best floating ability 
(91.47-72.97%) in 6 hours.  F5-F8 formulation showed less 
floating ability (66.12-45.09%) as showed in Table-3. 
   
 
Percentage buoyancy for different formulation 
Table 3: Percentage Buoyancy for Different Formulation 
Formulation 1 hour 2 hours 4 hours 6 hours 
F1 98.41 97.08 93.23 91.47 
F2 98.11 95.58 92.17 87.34 
F3 98.54 95.64 85.34 78.45 
F4 99.54 92.49 80.57 72.97 
F5 98.72 91.95 73.49 66.12 
F6 98.45 86.62 65.14 57.76 
F7 88.34 75.41 56.04 45.09 
F8 82.25 74.56 55.25 40.56 
 
 
Figure 3: Percentage Buoyancy for Different 
Formulation 
Drug Entrapment: 
The drug entrapment efficacies of different formulations 
were in range of 48.47 - 76.19 % w/w as shown in Table No- 
4.  Drug entrapment efficacy slightly decreases with increase 
EC content in Microspheres.  This is due to the permeation 
characteristics of that could facilitate the diffusion of part of 
entrapped drug to surrounding medium during preparation 
of Sulfasalazine microspheres.    
Drug entrapment for different formulation 
 
Figure 4: Drug Entrapment for Different Formulation 
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Table 4: Drug Entrapment for Different Formulation 
Formulation Drug entrapment   (% w/w) 
F1 75.56±0.21 
F2 70.12±0.32 
F3 70.21±0.54 
F4 68.89±0.41 
F5 65.56±0.25 
F6 63.25±0.38 
F7 62.25±0.25 
F8 58.98±0.24 
 
Percentage Yield: 
Percentage yield of different formulation was determined by 
weighing the Microspheres after drying.  The percentage 
yield of different formulation was in range of 56.84 - 82.87% 
as shown in Table-5. 
Table 5: Percentage Yield for Different Formulation 
Formulation Percent Yield (%) 
F1 82.87 
F2 78.53  
F3 76.47  
F4 71.56  
F5 69.31  
F6 66.03  
F7 56.84  
F8 52.25 
 
 
Figure 5: Percentage Yield for Different Formulation 
 
Scanning Electronic Microscopy: 
Shape and surface characteristic of Sulfasalazine 
microspheres examine by Scanning Electronic Microscopy 
analysis.  Surface morphology of formulation examines at 
different magnification, which illustrate the smooth surface 
of floating Microspheres. 
 
 
Figure 6: Scanning Electronic Microscopy Image of Optimized Formulation F-1 
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In-Vitro Drug release study:  
In vitro drug release study of Sulfasalazine loaded Floating Microsphere 
Comparative release study of all formulation  
Table 6: Comparative Release Study data of formulation F1-F8 
Time   
% of Drug Release 
(hr) F1 F2 F3 F4 F5 F6 F7 F8 
0.5 16.429 15.000 14.286 14.286 17.857 16.429 14.286 11.21 
1.0 26.536 18.607 18.571 18.571 28.036 25.821 22.857 21.47 
1.5 30.679 27.357 27.321 27.321 34.393 31.357 33.964 32.32 
2.0 57.107 32.929 32.893 32.893 43.857 43.536 39.143 34.61 
3.0 71.214 60.143 40.821 40.821 61.571 54.821 58.786 52.00 
4.0 81.607 77.214 52.643 52.643 71.500 78.000 56.464 42.28 
6.0 95.214 85.714 72.107 72.107 78.214 93.643 66.036 53.21 
8.0 100.036 90.179 86.714 86.714 95.107 99.893 95.250 81.93 
 
 
Graph of release study of formulation F1-F8 
 
  Figure 8: Graph of release study of formulation F1-F8  
Release Kinetics of Optimized Formulation F-1 
Graph of Zero order release kinetics of F-1 
 
Figure 9: Graph of Zero order release kinetics of F-1 
 
 
 
Figure 10: Graph of First order release kinetics of F-1 
 
Graph of Higuchi release Kinetics 
 
Figure 11: Graph of Higuchi release Kinetics
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Graph of Korsemayer – Papas Kinetics 
 
Figure 12: Graph of Korsemayer – Papas Kinetics 
Table 7: Comparative study of regression coefficient for 
selection of optimize Formulation F-7 
Zero order First order Higuchi Korsmayer 
r2 0.862 0.831 0.942 0.616 
 
The In vitro drug release data of the optimized formulation 
was subjected to goodness of fit test by linear regression 
analysis according to zero order, first order kinetic equation, 
Higuchi’s and Korsmeyer’s models in order to determine the 
mechanism of drug release. When the regression coefficient 
values of were compared, it was observed that ‘r’ values of 
Higuchi was maximum i.e 0.942 hence indicating drug 
release from formulations was found to follow Higuchi 
kinetics.  
CONCLUSION 
Floating microspheres of Sulfasalazine were prepared by the 
solvent evaporation technique. Sulfasalazineis a slightly 
water soluble drug which has good absorption in gastric pH. 
Sulfasalazine suffers from poor oral bioavailability since it is 
less soluble in water and shows poor absorption in lower 
GIT. Hence, such a drug requires a novel gastroretentive 
drug delivery system which can provide an extended period 
of time in stomach and improve oral bioavailability. 
Microspheres are the suitable drug delivery system for the 
drugs that have poor absorption from lower GIT. 
Microspheres were studied for characterization, 
compatibility study, particle size and shape, in vitro drug 
release, entrapment efficiency, and buoyancy time. The 
formulation using Ethyl cellulose and HPMC showed a 
constant rate of release. Thus, prepared floating 
microspheres of Sulfasalazine may prove to be potential 
candidates for a drug delivery. 
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